Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial.
Gräfe V, Moritz S, Greiner W (2020)
Health economics review 10: 19.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
s13561-020-00273-0.graefe.pdf
780.91 KB
Autor*in
Gräfe, ViolaUniBi;
Moritz, Steffen;
Greiner, WolfgangUniBi
Einrichtung
Abstract / Bemerkung
BACKGROUND: Depressive disorders often remain undiagnosed or are treated inadequately. Online-based programs may reduce the present treatment gap for depressive disorders and reduce disease-related costs. This study aimed to examine the potential of the internet intervention "deprexis" to reduce the total costs of statutory health insurance. Changes in depression severity, health-related quality of life and impairment in functioning were also examined.; METHOD: A total of 3805 participants with, at minimum, mild depressive symptoms were randomized to either a 12-week online intervention (deprexis) or a control condition. The primary outcome measure was statutory health insurance costs, estimated using health insurers' administrative data. Secondary outcomes were: depression severity, health-related quality of life, and impairment in functioning; assessed on patient's self-report at baseline, post-treatment, and three-months' and nine-months' follow-up.; RESULTS: In both groups, total costs of statutory health insurance decreased during the study period, but changes from baseline differed significantly. In the intervention group total costs decreased by 32% from 3139 per year at baseline to 2119 in the study year (vs. a mean reduction in total costs of 13% in the control group). In comparison to the control group, the intervention group also showed a significantly greater reduction in depression severity, and impairment in functioning and a significantly greater increase in health-related quality of life.; CONCLUSION: The study underlines the potential of innovative internet intervention programs in treating depressive disorders. The results suggest that the use of deprexis over a period of 12weeks leads to a significant improvement in symptoms with a simultaneous reduction in the costs of statutory health insurance.
Erscheinungsjahr
2020
Zeitschriftentitel
Health economics review
Band
10
Art.-Nr.
19
Urheberrecht / Lizenzen
eISSN
2191-1991
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2944321
Zitieren
Gräfe V, Moritz S, Greiner W. Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial. Health economics review. 2020;10: 19.
Gräfe, V., Moritz, S., & Greiner, W. (2020). Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial. Health economics review, 10, 19. doi:10.1186/s13561-020-00273-0
Gräfe, Viola, Moritz, Steffen, and Greiner, Wolfgang. 2020. “Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial.”. Health economics review 10: 19.
Gräfe, V., Moritz, S., and Greiner, W. (2020). Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial. Health economics review 10:19.
Gräfe, V., Moritz, S., & Greiner, W., 2020. Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial. Health economics review, 10: 19.
V. Gräfe, S. Moritz, and W. Greiner, “Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial.”, Health economics review, vol. 10, 2020, : 19.
Gräfe, V., Moritz, S., Greiner, W.: Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial. Health economics review. 10, : 19 (2020).
Gräfe, Viola, Moritz, Steffen, and Greiner, Wolfgang. “Health economic evaluation of an internet intervention for depression (deprexis), a randomized controlled trial.”. Health economics review 10 (2020): 19.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
s13561-020-00273-0.graefe.pdf
780.91 KB
Access Level
Open Access
Zuletzt Hochgeladen
2020-06-30T12:46:36Z
MD5 Prüfsumme
45afd7be367ea52ec5df478eb2d53bff
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 32548724
PubMed | Europe PMC
Suchen in